We recently published 10 Stocks Losing Big. ESSA Pharma Inc. (NASDAQ:EPIX) is one of the worst performers of Tuesday.

ESSA Pharma nosedived by 66.39 percent on Tuesday to end at $0.2631 apiece as investors sold off positions following the payment of $80 million to its shareholders as part of its business shutdown.

In a statement, ESSA Pharma Inc. (NASDAQ:EPIX) said it returned around $1.69 per share to shareholders as of August 22 record. It also corrected the ex-dividend date to August 22, instead of August 25 as it had earlier announced.

The transaction was in line with ESSA Pharma Inc.'s (NASDAQ:EPIX) planned merger with XenoTherapeutics, Inc., under which the latter will acquire all of its issued and outstanding shares.

Under the terms of the agreement, shareholders of ESSA Pharma Inc. (NASDAQ:EPIX) will receive a cash payment that will be determined based on its cash balance at closing after deducting certain transaction costs, a reserve for liabilities and legal expenses, and a transaction fee.

Additionally, each shareholder will receive one non-transferable contingent value right for each share, which will entitle the shareholder to receive a pro rata portion of up to $2.95 million or $0.06 per CVR within 18 months following the transaction.

While we acknowledge the potential of EPIX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.